Martin Basil Slade

Title: Martin Basil Slade: Innovator in Antibody Production

Introduction

Martin Basil Slade is an accomplished inventor based in New South Wales, Australia. He has made significant contributions to the field of immunology, particularly in the production of antibodies. His innovative work has led to the development of a method for producing IgG1 subclass antibodies that are reactive to the surface of Cryptosporidium oocysts.

Latest Patents

Martin Basil Slade holds a patent for "Antibodies to Cryptosporidium." This patent outlines a method that includes several steps: separating a portion of the Cryptosporidium oocyst wall from the internal sporozoites to create an oocyst-wall preparation, treating this preparation to obtain an oocyst antigen preparation, immunizing an animal with the antigen preparation to elicit an IgG1 immune response, and finally obtaining IgG1 antibodies from the animal that are reactive to the surface of Cryptosporidium oocysts. This innovative approach has the potential to advance the understanding and treatment of cryptosporidiosis.

Career Highlights

Throughout his career, Martin has focused on the intersection of immunology and biotechnology. His work has not only contributed to scientific knowledge but also has practical implications for public health. His patent reflects his dedication to addressing health challenges through innovative solutions.

Collaborations

Martin has collaborated with notable professionals in his field, including Graham Vesey and Keith Leslie Williams. These collaborations have enriched his research and contributed to the successful development of his patented methods.

Conclusion

Martin Basil Slade is a notable inventor whose work in antibody production has significant implications for immunology and public health. His innovative methods and collaborations highlight the importance of research in combating health challenges.